Stephanie Teal

ORCID: 0000-0002-0167-1071 · 4 papers in corpus
article 2022
Evaluation of ovulation and safety outcomes in a multi-center randomized trial of three 84 day ulipristal acetate regimens
·doi:10.1016/j.contraception.2022.04.002

ObjectivesTo describe ovulation inhibition and safety of daily oral ulipristal acetate (UPA) over 84 days.Study designThis multi-center phase 1 and/or 2 trial randomized participants to use oral ulipristal 10 mg or 5 mg daily or a 3 cycle r…

review 2021
Contraception Selection, Effectiveness, and Adverse Effects: A Review
JAMA ·doi:10.1001/jama.2021.21392

IMPORTANCE: Many women spend a substantial proportion of their lives preventing or planning for pregnancy, and approximately 87% of US women use contraception during their lifetime. OBSERVATIONS: Contraceptive effectiveness is determined b…

letter 2019
Letter to the Editor in Response to “Effect of Polymorphisms in CYP2C9 and CYP2C19 on the Disposition, Safety and Metabolism of Progesterone Administrated Orally or Vaginally”
·doi:10.1007/s12325-019-01195-y

Provide enhanced digital features for this article There are currently no enhanced digital features for this article. If you are an author of this publication and would like to provide additional enhanced digital features for your article t…

review 2007
Medical Therapies for Chronic Menorrhagia
·doi:10.1097/01.ogx.0000259228.70277.6f

An estimated 10%–30% of menstruating women experience menorrhagia at some time during their reproductive lives. Acute menorrhagia may present as an emergency requiring prompt medical or surgical intervention. Chronic menorrhagia affects a w…